Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prodrugs01:30

Prodrugs

3.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.7K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

4.1K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
4.1K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.8K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.6K
Principles of Drug Action01:24

Principles of Drug Action

7.8K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cation-free platform based on azocalixarene poly(disulfide)s for direct cytosolic protein delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Controlled Synthesis of Topologically Diverse Polyrotaxanes by Ring-Opening Polymerization of Mechanically Interlocked Monomers.

Journal of the American Chemical Society·2026
Same author

Chiral Micellar Assemblies for Circularly Polarized Luminescence Amplification, Dye Encapsulation, and Multilevel Information Encryption.

Angewandte Chemie (International ed. in English)·2026
Same author

Development of combined mutagenesis strategy for enhanced eicosapentaenoic acid production in Schizochytrium sp.

Bioresource technology·2026
Same author

Porous organic polymers based on deep-cavity calixarenes for broad-spectrum and high-affinity drug adsorption in the gastrointestinal tract.

Journal of materials chemistry. B·2026
Same author

Supramolecular delivery of senolytics enables targeted anti-senescence therapy and accelerated fracture healing.

Journal of nanobiotechnology·2026

Related Experiment Video

Updated: Dec 26, 2025

Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction
10:39

Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction

Published on: August 23, 2018

8.2K

Supramolecular prodrugs based on host-guest interactions.

Wen-Chao Geng1, Jonathan L Sessler, Dong-Sheng Guo

  • 1College of Chemistry, Key Laboratory of Functional Polymer Materials (Ministry of Education), State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, China. dshguo@nankai.edu.cn.

Chemical Society Reviews
|March 18, 2020
PubMed
Summary

Supramolecular prodrugs utilize host-guest chemistry for controlled drug release, offering advantages over traditional prodrugs. This approach enhances drug delivery through stimulus-induced release and improved pharmacokinetics.

More Related Videos

Synthesis and Characterization of Supramolecular Colloids
09:26

Synthesis and Characterization of Supramolecular Colloids

Published on: April 22, 2016

10.3K
Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags
10:10

Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags

Published on: January 17, 2019

11.2K

Related Experiment Videos

Last Updated: Dec 26, 2025

Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction
10:39

Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction

Published on: August 23, 2018

8.2K
Synthesis and Characterization of Supramolecular Colloids
09:26

Synthesis and Characterization of Supramolecular Colloids

Published on: April 22, 2016

10.3K
Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags
10:10

Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags

Published on: January 17, 2019

11.2K

Area of Science:

  • Supramolecular Chemistry
  • Medicinal Chemistry
  • Drug Delivery

Background:

  • Traditional prodrugs involve covalent drug modification to improve pharmacokinetics and administration.
  • Supramolecular chemistry offers a novel prodrug strategy using host-guest complexes.
  • These complexes enable controlled release of active drugs upon specific stimuli.

Purpose of the Study:

  • To review the concept and progress of supramolecular prodrugs based on host-guest chemistry.
  • To highlight the advantages of supramolecular prodrugs in drug delivery.
  • To discuss limitations and future opportunities in this field.

Main Methods:

  • Review of existing literature on supramolecular chemistry and prodrug design.
  • Analysis of host-guest complex formation for drug encapsulation and release.
  • Evaluation of stimulus-responsive mechanisms for controlled drug delivery.

Main Results:

  • Supramolecular prodrugs offer ease of preparation and molecular-level protection for drugs.
  • These systems demonstrate sensitive responses to biological stimuli for targeted release.
  • Traceless release mechanisms and adaptability to various drugs are key benefits.

Conclusions:

  • Supramolecular prodrugs represent a promising advancement in drug delivery systems.
  • The host-guest complex approach provides significant advantages over conventional prodrug strategies.
  • Further research into supramolecular prodrugs can unlock new therapeutic possibilities.